Scientific Director, Breast Cancer Portfolio

Portfolio Evidence Strategy:

• Serve as scientific lead for the breast cancer evidence portfolio, ensuring continuity and alignment with long-term objectives.
• Develop integrated evidence-generation strategies across all breast cancer products, including both in-development and commercial assays.
• Define evidence requirements for regulatory submissions, reimbursement, clinical adoption, and guideline inclusion.

Clinical and Translational Research Leadership:

• Partner with internal and external stakeholders to prioritize clinical datasets supporting portfolio evidence goals.
• Provide scientific oversight of retrospective, prospective, observational, and translational studies.
• Develop study concepts, protocols, and endpoints in collaboration with Biostatistics and Medical teams.

External Scientific Collaborations:

• Establish and maintain relationships with key opinion leaders, academic medical centers, and research networks.
• Serve as primary scientific contact for investigators in collaborative studies.
• Lead scientific discussions throughout study development and execution.

Scientific Communication and Publication:

• Develop publication strategies and lead preparation of abstracts, posters, and peer-reviewed manuscripts.
• Translate study findings into clinically meaningful evidence.
• Present scientific data internally and externally to advance product development.